TL
Tirschwell & Loewy Portfolio holdings
AUM
$731M
This Quarter Return
+10.6%
1 Year Return
+15.45%
3 Year Return
+77.97%
5 Year Return
+97.59%
10 Year Return
–
AUM
$618M
AUM Growth
+$618M
(+11%)
Cap. Flow
+$4.53M
Cap. Flow
% of AUM
0.73%
Top 10 Holdings %
Top 10 Hldgs %
40.81%
Holding
81
New
1
Increased
26
Reduced
35
Closed
5
Top Buys
| 1 |
Starbucks
SBUX
|
$8.63M |
| 2 |
BIVV
Bioverativ Inc. Common Stock
BIVV
|
$2.03M |
| 3 |
Dentsply Sirona
XRAY
|
$1.04M |
| 4 |
Mastercard
MA
|
$845K |
| 5 |
Williams-Sonoma
WSM
|
$644K |
Top Sells
| 1 |
Wells Fargo
WFC
|
$4.78M |
| 2 |
Southern Company
SO
|
$2.57M |
| 3 |
Fortive
FTV
|
$1.71M |
| 4 |
Cognex
CGNX
|
$1.54M |
| 5 |
Coca-Cola
KO
|
$829K |
Sector Composition
| 1 | Healthcare | 41.03% |
| 2 | Technology | 12.51% |
| 3 | Industrials | 11.73% |
| 4 | Consumer Staples | 7.1% |
| 5 | Consumer Discretionary | 5.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Cognex
CGNX
$7.38B
| $35.9M | 5.81% |
427,740
-18,320
| -4% | -$1.54M |
|
|
TIF
2
DELISTED
Tiffany & Co.
TIF
| $33.8M | 5.48% |
354,996
-1,600
| -0.4% | -$152K |
|
3
Analog Devices
ADI
$124B
| $26.2M | 4.24% |
319,581
-370
| -0.1% | -$30.3K |
|
4
Johnson & Johnson
JNJ
$427B
| $25M | 4.05% |
200,906
-760
| -0.4% | -$94.7K |
|
5
Idexx Laboratories
IDXX
$51.8B
| $25M | 4.05% |
161,735
-4,205
| -3% | -$650K |
|
6
Neogen
NEOG
$1.25B
| $22.5M | 3.64% |
342,734
-1,555
| -0.5% | -$102K |
|
7
DexCom
DXCM
$29.5B
| $22.2M | 3.59% |
261,670
-600
| -0.2% | -$50.8K |
|
8
Biogen
BIIB
$19.4B
| $20.9M | 3.39% |
76,580
-675
| -0.9% | -$185K |
|
9
Danaher
DHR
$147B
| $20.3M | 3.29% |
237,531
+415
| +0.2% | +$35.5K |
|
|
RTN
10
DELISTED
Raytheon Company
RTN
| $20.3M | 3.29% |
133,192
+295
| +0.2% | +$45K |
|
11
Brown-Forman Class B
BF.B
$14.2B
| $20M | 3.23% |
432,039
-7,904
| -2% | -$365K |
|
12
Honeywell
HON
$139B
| $19.9M | 3.23% |
159,622
-900
| -0.6% | -$112K |
|
|
13
Mastercard
MA
$538B
| $17.3M | 2.8% |
153,670
+7,515
| +5% | +$845K |
|
14
Henry Schein
HSIC
$8.44B
| $16.8M | 2.72% |
98,839
+1,295
| +1% | +$220K |
|
15
Schlumberger
SLB
$55B
| $14.1M | 2.28% |
180,177
-855
| -0.5% | -$66.8K |
|
16
Novo Nordisk
NVO
$251B
| $13.9M | 2.25% |
406,195
+5,800
| +1% | +$199K |
|
17
Amgen
AMGN
$155B
| $13.6M | 2.19% |
82,597
+165
| +0.2% | +$27.1K |
|
18
Insulet
PODD
$23.9B
| $13M | 2.1% |
301,555
+830
| +0.3% | +$35.8K |
|
19
Inogen
INGN
$216M
| $12.8M | 2.08% |
165,565
+365
| +0.2% | +$28.3K |
|
20
W.W. Grainger
GWW
$48.5B
| $12.7M | 2.05% |
54,372
-1,205
| -2% | -$280K |
|
|
21
Starbucks
SBUX
$100B
| $12.4M | 2% |
211,605
+147,755
| +231% | +$8.63M |
|
|
22
Dentsply Sirona
XRAY
$2.85B
| $11.7M | 1.89% |
187,111
+16,636
| +10% | +$1.04M |
|
23
Ross Stores
ROST
$48.1B
| $11.1M | 1.8% |
168,835
+1,075
| +0.6% | +$70.8K |
|
24
Mettler-Toledo International
MTD
$26.8B
| $10.1M | 1.64% |
21,145
+35
| +0.2% | +$16.8K |
|
|
ABMD
25
DELISTED
Abiomed Inc
ABMD
| $10.1M | 1.64% |
80,705
+290
| +0.4% | +$36.3K |
|